NCT01086969View on ClinicalTrials.gov

A Study of Meningococcal Vaccine, Menactra® in Healthy Subjects in India

PHASE3CompletedINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

June 30, 2010

Primary Completion Date

February 28, 2011

Study Completion Date

June 30, 2011

Conditions
Meningococcal InfectionMeningitis
Interventions
BIOLOGICAL

Meningococcal Polysaccharide Diphtheria Toxoid Conjugate (Menactra®)

0.5 mL, Intramuscular

Trial Locations (3)

110002

New Delhi

400022

Mumbai

560070

Bangalore

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
lead

Sanofi

INDUSTRY